Answer
Azacitidine is believed to exert anticancer effects through cytotoxicity against abnormal bone-marrow blood-forming cells and DNA methyltransferase inactivation, causing DNA hypomethylation that may restore cancer-suppressing gene functions; the relative importance of these mechanisms to clinical outcomes is unestablished.
Sources for this answer
- Vidaza 25 mg/ml powder for suspension for injectionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 25Document updated
Sources checked